Announced Thu, 1 Oct, 2026 · 15:58 IST
AGM 2026 voting results: all 6 resolutions passed unanimously
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹2055.00
prior close
₹2064.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+1.5+2.3+5.2-2.7-3.1-6.6———————
Up moveDown movePending
AI summary
Beta Drugs Limited held its 21st AGM on September 30, 2026. All 6 resolutions passed unanimously with 60,75,165 shares (100 percent) voted in favor and none against. Resolutions covered adoption of FY26 financial statements, re-appointment of directors Mr. Ajay Mahipal and Mr. Ashutosh Shukla by rotation, re-appointment of Statutory Auditors, ratification of Cost Auditor pay for FY27, and Mr. Shukla as Whole-time Director for 5 years from Jan 20, 2027 with revised pay.
Likely market impact
Routine procedural update. All resolutions passed unanimously, showing strong shareholder alignment. No dissent on the director pay revision.